Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,646.40
(
1.31%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
110.85
(
-1.36%
)
Bitcoin
75,775.26
(
0.00%
)
News Focus
News Focus
Post# of 257470
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122909
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dangerM post# 226449

Thursday, 10/17/2019 6:14:02 PM

Thursday, October 17, 2019 6:14:02 PM

Post# of 257470

I am not sure if I read about this…but would extra-cellular HBsAg be an antibody sink?

Perhaps you read this 2017 paper, where anti-HBsAg antibodies were directed against extracellular HBsAg in mice as an adjunct to vaccination: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824405/.

The role of HBsAg in chronic HBV remains poorly understood, which is why we are having this discussion!

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today